Medigus (Omer, Israel) has received FDA clearance for its SRS endoscopic system for treatment of gastroesophageal reflux disease (GERD). With the SRS system a minimally-invasive anterior fundoplication can be performed, something which normally requires laparoscopic surgery or laparotomy.
The SRS flexible endoscope combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. The endoscope is inserted into the esophagus through the mouth and enables the operator to perform an anterior fundoplication endoluminally. Depending on the specific anatomy of the patient, two or three staplings are placed to restore a normal gastroesophageal valve. The procedure is performed under general anesthesia and takes approximately 45 to 60 minutes in total.
In contrast with previous endoscopic solutions for GERD treatment which created a controlled stricture at the GE junction, the result of the SRS system is functionally identical to a standard laparoscopic surgical procedure anterior fundoplication. An early study with the device showed an efficacy rate of 75% together with a low complication rate. Medigus already received CE mark approval for the SRS system earlier. The video below explains the procedure in more detail:
Flashback: SRS System: Endoscopic Partial Anterior Fundoplication
Press release: SRS Endoscopic System Receives FDA Clearance for Treatment of Gastroesophageal Reflux Disease (GERD)…
Product page: SRS Endoscope…